Abstract:The ability to self-assemble one-dimensional DNA building blocks into two- and three-dimensional nanostructures via DNA/RNA nanotechnology has led to broad applications in bioimaging, basic biological mechanism studies, disease diagnosis, and drug delivery. However, the cellular uptake of most nucleic acid nanostructures is dependent on passive delivery or the enhanced permeability and retention effect, which may not be suitable for certain types of cancers, especially for treatment in vivo. To meet this need, we have constructed a multifunctional aptamer-based DNA nanoassembly (AptNA) for targeted cancer therapy. In particular, we first designed various Y-shaped functional DNA domains through predesigned base pair hybridization, including targeting aptamers, intercalated anticancer drugs, and therapeutic antisense oligonucleotides. Then these functional DNA domains were linked to an X-shaped DNA core connector, termed a building unit, through the complementary sequences in the arms of functional domains and connector. Finally, hundreds (~100-200) of these basic building units with 5'-modification of acrydite groups were further photo-cross-linked into a multifunctional and programmable aptamer-based nanoassembly structure able to take advantage of facile modular design and assembly, high programmability, excellent biostability and biocompatibility, as well as selective recognition and transportation. With these properties, AptNAs were demonstrated to have specific cytotoxic effect against leukemia cells. Moreover, the incorporation of therapeutic antisense oligonucleotides resulted in the inhibition of P-gp expression (a drug efflux pump to increase excretion of anticancer drugs) as well as a decrease in drug resistance. Therefore, these multifunctional and programmable aptamer-based DNA nanoassemblies show promise as candidates for targeted drug delivery and cancer therapy.

Design of a Membrane-Anchored DNAzyme-Based Molecular Machine for Enhanced Cancer Therapy by Customized Cascade Regulation

Combination Cancer Treatment: Using Engineered DNAzyme Molecular Machines for Dynamic Inter‐ and Intracellular Regulation

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

Programing Immunogenic Cell Death in Breast Tumors with Designer DNA Frameworks

A Chimeric Conjugate of Antibody and Programmable DNA Nanoassembly Smartly Activates T Cells for Precise Cancer Cell Targeting

A Self‐Catabolic Multifunctional DNAzyme Nanosponge for Programmable Drug Delivery and Efficient Gene Silencing

Programming a DNA Tetrahedral Nanomachine As an Integrative Tool for Intracellular Microrna Biosensing and Stimulus-Unlocked Target Regulation

Engineering a Customized Nanodrug Delivery System at the Cellular Level for Targeted Cancer Therapy.

Activating a DNA Nanomachine Via Computation Across Cancer Cell Membranes for Precise Therapy of Solid Tumors.

An Aptamer‐Functionalized DNA Circuit to Establish an Artificial Interaction Between T Cells and Cancer Cells

Tunable Multivalent Aptamer-Based DNA Nanostructures to Regulate Multiheteroreceptor-Mediated Tumor Recognition.

Telomerase-Mediated Self-Assembly of DNA Network in Cancer Cells Enabling Mitochondrial Interference.

Programming DNA cascade circuits on live cell membranes for accurate cancer cell recognition and gene silencing

Advances in intelligent DNA nanomachines for targeted cancer therapy

Logic Nanodevice-Mediated Receptor Assembly for Nongenetic Regulation of Cell Behavior in Tumor-like Microenvironment

Building a Multifunctional Aptamer-Based DNA Nanoassembly for Targeted Cancer Therapy.

Enhancing Cell Membrane Phase Separation for Inhibiting Cancer Metastasis with a Stimuli-Responsive DNA Nanodevice

Programmable and Multiparameter DNA-based Logic Platform for Cancer Recognition and Targeted Therapy.

DNA logic gate for cancer cells identification, detection, and modulation of cell–cell interactions

A Multifunctional DNA Nanoassembly for Cancer Cell Detection and Combined Gene-Chemotherapy Therapy.

Engineering a Second‐Order DNA Logic‐Gated Nanorobot to Sense and Release on Live Cell Membranes for Multiplexed Diagnosis and Synergistic Therapy